IL13Ralpha2-CAR T Cells

IL13Ralpha2-targeted CAR T cells · City of Hope Medical Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IL13Ralpha2-CAR T Cells, covering 2026-03-05 to 2026-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma [Phase 1]

See pricing